Form 4: Orthofix CFO Sells Shares for Tax Obligations
Insider Transaction Report
Orthofix Medical Inc.'s CFO, Julie Andrews, sold 4,873 shares of common stock at $14.38 per share to cover tax withholding obligations related to restricted stock unit settlement.
Summary
- Julie Andrews, Chief Financial Officer (CFO) of Orthofix Medical Inc. (OFIX), reported a transaction involving the company's common stock.
- On January 16, 2026, Ms. Andrews disposed of 4,873 shares of common stock.
- The shares were sold at a price of $14.38 per share.
- The sale was conducted to satisfy tax withholding obligations in connection with the settlement of restricted stock units.
- This transaction was a 'sell-to-cover' requirement, pre-existing, and previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors.
- The sale was made without the exercise of any discretion by the reporting person.
- Following this transaction, Ms. Andrews beneficially owns 58,039 shares of common stock, which includes 45,590 previously reported restricted stock units.
Sentiment
Score: 5
Explanation: The transaction is neutral as it represents a routine, non-discretionary sale of shares to cover tax obligations associated with restricted stock unit vesting, rather than a discretionary sale based on market outlook.
Positives
- The transaction was non-discretionary and pre-approved by the Compensation and Talent Development Committee, indicating adherence to established corporate policy and tax compliance.
Negatives
- A reduction in direct share ownership by a key executive, although for a routine and non-discretionary purpose.
Stakeholder Impact
- Shareholders: A minor reduction in direct insider ownership, which is generally not a significant concern given the non-discretionary nature of the sale for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 01/16/2026 | Date of transaction where 4,873 shares of common stock were sold. |
| 01/21/2026 | Date the Form 4 filing was signed by the attorney-in-fact. |
Recommendation
holdThis Form 4 filing details a routine, non-discretionary 'sell-to-cover' transaction by the CFO to satisfy tax obligations from restricted stock unit settlement. Such transactions are common and do not typically reflect a change in management's outlook on the company's prospects. Therefore, this specific filing does not provide new information that would warrant a change from a 'hold' recommendation.
Keywords
Orthofix, OFIX, Form 4, Insider Transaction, CFO, Stock Sale, Restricted Stock Units, Tax Withholding, Sell-to-Cover
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.